专利检索 ap:("Philip E. Brandish" OR "Mei Chen" OR "Andrey Loboda" OR "Michael Nebozhyn, III" OR "Cai Wu" OR "Daping Zhang" OR "Jie Zhang-Hoover") AND inv:"Cai Wu" 第 1 页

1.

发明公开
METHODS FOR TREATING CANCER WITH ANTI-ILT3 ANTIBODIES 审中-公开

公开(公告)号：US20240317854A1

公开(公告)日：2024-09-26

申请号：US18550537

申请日：2022-03-17

申请人： Philip E. Brandish , Mei Chen , Andrey Loboda , Michael Nebozhyn, III , Cai Wu , Daping Zhang , Jie Zhang-Hoover

发明人： Philip E. Brandish , Mei Chen , Andrey Loboda , Michael Nebozhyn, III , Cai Wu , Daping Zhang , Jie Zhang-Hoover

IPC分类号： C07K16/28 , A61K31/337 , A61K31/7068 , A61K39/00 , A61K39/395 , A61P35/00

CPC分类号： C07K16/2803 , A61K31/337 , A61K31/7068 , A61K39/3955 , A61P35/00 , C07K16/2818 , A61K2039/505 , A61K2039/507 , A61K2039/545

摘要： This disclosure relates to methods for treating solid tumors in a patient identified as having metastatic triple negative breast cancer, glioblastoma, metastatic pancreatic ductal adenocarcinoma, metastatic soft tissue sarcoma, or metastatic non-squamous non-small cell lung carcinoma, comprising administering an anti-ILT3 antigen binding protein, or antigen binding fragment, and an anti-PD1 antigen binding protein, or antigen binding fragment, to the patient every three weeks (Q3W).